Brege Laura sold Mirum Pharmaceuticals ($MIRM) shares on the open market twice in the last year, totaling about $1.26 million, with the most recent sale on September 11, 2025. Her $MIRM sales rank 4,390th among individual insiders. She also sold ACADIA Pharmaceuticals ($ACAD) shares once for about $315,000 on June 4, 2025, ranking 7,439th. Across 11,678 insiders, the average sale totals 8.6 million over 6.4 transactions. Brege Laura made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 11, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Brege Laura | Not found | M | Common Stock | 17000 | $15.00 | 32,703.0000 | 47,522,594 | 108.26% | 0.04% |
| Sept. 11, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Brege Laura | Not found | S | Common Stock | 1491 | $75.07 | 15,703.0000 | 47,522,594 | 8.67% | 0.00% |
| Sept. 11, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Brege Laura | Not found | S | Common Stock | 15509 | $74.34 | 17,194.0000 | 47,522,594 | 47.42% | 0.03% |
| Sept. 11, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Brege Laura | Not found | M | Stock Option (right to buy) | 17000 | $0.00 | 0.0000 | 47,522,594 | 100.00% | 0.04% |
| June 16, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Brege Laura | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 95,130,053 | 9999.99% | 0.03% |
| June 11, 2025 | Pacira BioSciences, Inc. | $PCRX | Brege Laura | Director | A | Stock Option (Right to Buy) | 11279 | $0.00 | 11,279.0000 | 46,245,000 | 9999.99% | 0.02% |
| June 11, 2025 | Pacira BioSciences, Inc. | $PCRX | Brege Laura | Director | A | Common Stock | 6163 | $0.00 | 23,715.0000 | 46,245,000 | 35.11% | 0.01% |
| June 4, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Not found | S | Common Stock | 14446 | $21.78 | 15,095.0000 | 166,362,000 | 48.90% | 0.01% |
| May 29, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Brege Laura | Not found | M | Restricted Stock Units | 5703 | $0.00 | 0.0000 | 47,522,594 | 100.00% | 0.01% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Not found | M | Common Stock | 9387 | $0.00 | 29,541.0000 | 166,362,000 | 46.58% | 0.01% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Not found | M | Restricted Stock Units | 9387 | $0.00 | 0.0000 | 166,362,000 | 100.00% | 0.01% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Not found | A | Director Stock Options (Right to Buy) | 13793 | $0.00 | 13,793.0000 | 166,362,000 | 9999.99% | 0.01% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Not found | A | Restricted Stock Units | 8107 | $0.00 | 8,107.0000 | 166,362,000 | 9999.99% | 0.00% |
| May 29, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Brege Laura | Not found | M | Common Stock | 5703 | $0.00 | 15,703.0000 | 47,522,594 | 57.03% | 0.01% |
| May 29, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Brege Laura | Not found | A | Stock Option (right to buy) | 6268 | $0.00 | 6,268.0000 | 47,522,594 | 9999.99% | 0.01% |
| May 29, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Brege Laura | Not found | A | Deferred Stock Units | 3977 | $0.00 | 3,977.0000 | 47,522,594 | 9999.99% | 0.01% |
| Aug. 16, 2024 | Pacira BioSciences, Inc. | $PCRX | Brege Laura | Director | P | Common Stock | 1000 | $12.81 | 17,552.0000 | 51,979,000 | 6.04% | 0.00% |
| June 12, 2024 | Pacira BioSciences, Inc. | $PCRX | Brege Laura | Director | A | Common Stock | 5230 | $0.00 | 16,552.0000 | 51,979,000 | 46.19% | 0.01% |
| June 12, 2024 | Pacira BioSciences, Inc. | $PCRX | Brege Laura | Director | A | Stock Option (Right to Buy) | 12179 | $0.00 | 12,179.0000 | 51,979,000 | 9999.99% | 0.02% |
| June 10, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Brege Laura | Not found | A | Stock Option (Right to Buy) | 20594 | $0.00 | 20,594.0000 | 87,567,307 | 9999.99% | 0.02% |
| June 5, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | Brege Laura | Not found | A | Stock Option (right to buy) | 8779 | $0.00 | 8,779.0000 | 40,885,124 | 9999.99% | 0.02% |
| June 5, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | Brege Laura | Not found | A | Restricted Stock Units | 5703 | $0.00 | 5,703.0000 | 40,885,124 | 9999.99% | 0.01% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Not found | M | Restricted Stock Units | 6652 | $0.00 | 0.0000 | 163,819,000 | 100.00% | 0.00% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Not found | M | Common Stock | 6652 | $0.00 | 20,154.0000 | 163,819,000 | 49.27% | 0.00% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Not found | A | Restricted Stock Units | 9387 | $0.00 | 9,387.0000 | 163,819,000 | 9999.99% | 0.01% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Not found | A | Director Stock Options (Right to Buy) | 15959 | $0.00 | 15,959.0000 | 163,819,000 | 9999.99% | 0.01% |
| June 14, 2023 | Pacira BioSciences, Inc. | $PCRX | Brege Laura | Director | A | Common Stock | 1775 | $0.00 | 11,322.0000 | 46,538,000 | 18.59% | 0.00% |
| June 14, 2023 | Pacira BioSciences, Inc. | $PCRX | Brege Laura | Director | A | Stock Option (Right to Buy) | 12925 | $0.00 | 12,925.0000 | 46,538,000 | 9999.99% | 0.03% |
| June 12, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Director | S | Common Stock | 4500 | $24.87 | 13,502.0000 | 161,683,000 | 25.00% | 0.00% |
| June 5, 2023 | Pacira BioSciences, Inc. | $PCRX | Brege Laura | Director | S | Common Stock | 600 | $38.74 | 9,547.0000 | 46,538,000 | 5.91% | 0.00% |
| June 22, 2021 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Director | M | Restricted Stock Units | 3059 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 22, 2021 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Director | M | Common Stock | 3059 | $0.00 | 3,059.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2022 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Director | M | Common Stock | 6391 | $0.00 | 9,450.0000 | 0 | 208.92% | 0.00% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Director | M | Common Stock | 8552 | $0.00 | 18,002.0000 | 161,683,000 | 90.50% | 0.01% |
| June 7, 2022 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Director | M | Restricted Stock Units | 6391 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Director | M | Restricted Stock Units | 8552 | $0.00 | 0.0000 | 161,683,000 | 100.00% | 0.01% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Director | A | Director Stock Options (Right to Buy) | 11045 | $0.00 | 11,045.0000 | 161,683,000 | 9999.99% | 0.01% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Director | A | Restricted Stock Units | 6652 | $0.00 | 6,652.0000 | 161,683,000 | 9999.99% | 0.00% |
| April 3, 2023 | Pacira BioSciences, Inc. | $PCRX | Brege Laura | Director | M | Common Stock | 7000 | $29.90 | 17,147.0000 | 46,538,000 | 68.99% | 0.02% |
| April 3, 2023 | Pacira BioSciences, Inc. | $PCRX | Brege Laura | Director | M | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 46,538,000 | 100.00% | 0.02% |
| April 3, 2023 | Pacira BioSciences, Inc. | $PCRX | Brege Laura | Director | S | Common Stock | 7000 | $40.72 | 10,147.0000 | 46,538,000 | 40.82% | 0.02% |
| Jan. 12, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Director | M | Stock Option (Right to Buy) | 12500 | $0.00 | 0.0000 | 161,683,000 | 100.00% | 0.01% |
| Jan. 12, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Director | S | Common Stock | 12500 | $18.25 | 0.0000 | 161,683,000 | 100.00% | 0.01% |
| Jan. 12, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Brege Laura | Director | M | Common Stock | 12500 | $17.01 | 12,500.0000 | 161,683,000 | 9999.99% | 0.01% |